DK
Disha Karale
Investor at BoxGroup
New York City Metropolitan Area
Overview
Disha Karale is currently an Investor at BoxGroup, with previous experience at Accel, Allogene Therapeutics, and Celularity, Inc. She holds a Bachelor of Science in Economics from The Wharton School and a Bachelor of Arts from the University of Pennsylvania. Karale specializes in investing in various sectors including Drug Delivery, Digital Health, E-commerce, and AI, focusing on Seed and Pre-seed stages.
Work Experience
Investor
2023 - Current
Early Stage Investing
BoxGroup is an early-stage investment fund that invests in technology companies.
Investor
2022 - 2022
Growth Investing
Accel is an seed and growth-stage venture capital firm that helps a global community of entrepreneurs.
R&D Scientist
2021 - 2021
Solid Tumor CAR-T Cell Immunotherapy Group
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Raised $891,770,409.00 from Franklin Templeton, Jennison Associates, venBio Select Advisor, Fidelity, Deerfield Capital Management, Surveyor Capital, Perceptive Advisors, T. Rowe Price and Cowen Investment Management.